In this setting, causation would likely require ev
Post# of 148256
(Total Views: 648)
Posted On: 02/22/2022 2:17:20 AM
Quote:
In this setting, causation would likely require evidence demonstrating that a competently submitted application would more likely than not have been approved by the FDA and that the subsequent marketing of LL would more likely than not have generated profits within a given range to a reasonable degree of economic certainty.
By the time it gets in front of a jury there's a good chance that the HIV BLA will already be approved.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼